Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.725
-0.055 (-1.46%)
Apr 6, 2026, 4:00 PM EDT - Market closed
Evaxion Market Cap
Evaxion has a market cap or net worth of $31.07 million as of April 7, 2026. Its market cap has increased by 166.54% in one year.
Market Cap
31.07M
Enterprise Value
15.34M
1-Year Change
166.54%
Ranking
Category
Stock Price
$3.73
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $31.07M, a decrease of -83.82%. That is a compound annual growth rate of -29.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 31.53M | -20.75% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 33.93M |
| Palatin Technologies | 33.64M |
| Pluri | 33.37M |
| Dyadic International | 32.43M |
| INmune Bio | 32.17M |
| Apollomics | 31.61M |
| Longeveron | 31.33M |
| Actinium Pharmaceuticals | 30.56M |